Skip to main content
. 2013 May 6;210(5):917–931. doi: 10.1084/jem.20122308

Figure 1.

Figure 1.

IL-23 signature genes are increased in aberrant crypt lesions of Hh+AOM-treated mice. (A) Treatment scheme (left) and H&E-stained invasive colorectal-carcinoma in Hh+AOM-treated 129SvEv.Rag−/− mice (right; bar, 100 µm). Arrows represent atypical glands breaching the muscularis mucosa. (B) Quantitative PCR analysis showing levels of mRNA of the cytokines Il-23, Il-17, and Il-22, the matrix metalloproteinases Mmp9 and Mmp2, the EGF receptor ligand amphiregulin (Areg), and Hif1a, Vegfa, and Ptgs2 (Cox-2) in tumors versus surrounding normal tissue (n = 5–7). Graphs show a representative experiment out of two independently performed. *, P < 0.05; **, P < 0.01; ***, P < 0.001, paired Student’s t test.